Evan David Seigerman
Stock Analyst at BMO Capital
(3.7)
Main Sectors:
Top Industries:
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
REGN Regeneron Pharmaceut... | Maintains: Outperform | 600 640 | 591.01 | 8.29% | 8 | Aug 4, 2025 | |
REPL Replimune Group | Downgrades: Underperform | 27 2 | 5.25 | -61.9% | 4 | Jul 23, 2025 | |
NGNE Neurogene | Maintains: Outperform | 22 26 | 19.61 | 32.59% | 2 | Jun 12, 2025 | |
MRUS Merus | Maintains: Outperform | 96 110 | 64.43 | 70.73% | 1 | May 23, 2025 | |
ACAD ACADIA Pharmaceutica... | Maintains: Outperform | 24 28 | 24.94 | 12.27% | 2 | May 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 20 10 | 7.1 | 40.85% | 1 | May 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | 105 64 | 54.32 | 17.82% | 6 | Apr 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Market Perform | 105 96 | 84.66 | 13.39% | 4 | Feb 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 208 215 | 209.11 | 2.82% | 7 | Feb 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 362 346 | 296.45 | 16.71% | 4 | Jan 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | 52 57 | 56.99 | 0.02% | 3 | Jul 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 83 100 | 18.57 | 438.5% | 2 | Jun 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Outperform | 33 36 | 25.38 | 41.84% | 4 | May 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Market Perform | 31 72 | 58.7 | 22.66% | 4 | Oct 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 9 3 | 5.56 | -46.04% | 1 | May 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 369 396 | 705.14 | -43.84% | 1 | Sep 6, 2022 |